Thoracic spinal canal tumors are easily confused with other diseases

People first think that there is something wrong with the lungs and heart. Professor Fan Tao, director of the spinal and spinal cord diagnosis and treatment center of the three Bo Brain Hospital, said chest pain and chest tightness may also be caused by thoracic spinal canal tumors. In addition to supporting humans to walk upright, another important function of the human spine is that it constitutes a bony canal, the spinal canal. The spinal cord and nerves contained in the spinal canal act as a "wire network" between the brain and the trunk of the limbs, controlling a series of important functions such as limbs, urine and defecation. In adults, the diameter of the vertebral canal is usually as thick as one index finger. If tumors grow inside and outside the spinal canal, even if they are very small, they may directly compress the spinal cord nerve. Vertebral canal tumors are a common disease, which can cause pain in neck, chest, waist, leg and so on. Therefore, they are easy to be confused with other diseases.
90% above spinal canal tumors are benign, the proportion of malignant tumors is small, and most of benign spinal canal tumors can be cured by microsurgery. The symptoms caused by thoracic spinal canal tumors are not necessarily manifested only in the chest, but also in abdominal tightening, numbness and weakness of lower limbs, so they are often diagnosed and treated according to chest and lumbar diseases. However, if not correctly diagnosed and treated, it will lead to the development of the disease, resulting in dysfunction or paralysis of the patient's urine and urine, and a few patients will even be fatal due to metastasis. Experts warn that many patients have misunderstandings. They think that they can be diagnosed by CT and X-ray. In fact, the most appropriate examination is nuclear magnetic resonance. For thoracic spinal canal tumors, surgery is the main treatment method at present. Thoracic spinal canal tumors surgery is a difficult operation, which requires high technical level and supporting equipment of doctors. Therefore, once diagnosed, patients must choose a regular hospital for medical treatment.
Looking for chemical products? Let suppliers reach out to you!
2026-07-10
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The Neglected 'last mile' to Fight cancer
-
Kangvanda's first oncolytic vaccinia virus product V01 clinical application accepted
-
ASKG915 for Injection, a subsidiary of AskG915, was approved in the US
-
China's original 'non-invasive' surgical equipment is exported to Colombia for clinical treatment and research in the country
-
Insights of nutrition management for oncology patients
-
What Is The Potential of NAMPT, A Target in The Tumor Field? Could It be The Next Hot Track?
-
The next national procurement target for medical devices: spinal consumables
-
FDA approves first drug for treatment of oocytic plasmacytoid dendritic cell
-
U.S. API Dependence Turns Pharmaceutical Ingredients Into a National Security Issue
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
Recommend Reading
-
Reducing to Refocus: Novo Nordisk’s 9,000-Job Cut and the Strategic Realignment in Pharma
-
Haryana’s Drug Crackdown Gets Massive Public Support State Launches Podcast to Boost Community Involvement
-
Wall Street Predicts New Obesity Pills Will Be Priced Near $1000 Like Wegovy and Zepbound Supply and Competition Pressures Mount
-
Glenmark Targets 10–15 Percent CAGR in India by Shifting to High-Margin Drugs AbbVie Deal and New Launches Boost Outlook
-
Eisai Pharma Unveils Bold Plan: $100 Million Global Center Set to Transform Visakhapatnam Now
-
Insufficient Market Demand, DMF Market Prices Narrowly Fluctuate
-
Insufficient Support, N-Butanol Market in China Struggles to Improve
-
Geopolitical Risks Escalate, Acrylonitrile Prices Rise Driven by Cost Increases in China
-
Hormuz in Crisis: Freight Rates Surge to $6,000 as Global Trade Feels the Shock
-
Production and Sales Pressure Eases; PC Prices Stabilize for Late November